Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Restructuring Costs (2022 - 2025)

Historic Restructuring Costs for Marimed (MRMD) over the last 4 years, with Q3 2025 value amounting to $145000.0.

  • Marimed's Restructuring Costs fell 6091.64% to $145000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $542000.0, marking a year-over-year decrease of 3645.96%. This contributed to the annual value of $951000.0 for FY2024, which is 3683.45% up from last year.
  • Marimed's Restructuring Costs amounted to $145000.0 in Q3 2025, which was down 6091.64% from $139000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Restructuring Costs registered a high of $754000.0 during Q2 2022, and its lowest value of $32000.0 during Q3 2023.
  • Over the past 4 years, Marimed's median Restructuring Costs value was $144000.0 (recorded in 2022), while the average stood at $214500.0.
  • As far as peak fluctuations go, Marimed's Restructuring Costs plummeted by 7762.24% in 2023, and later soared by 105937.5% in 2024.
  • Over the past 4 years, Marimed's Restructuring Costs (Quarter) stood at $64000.0 in 2022, then dropped by 25.0% to $48000.0 in 2023, then surged by 204.17% to $146000.0 in 2024, then decreased by 0.68% to $145000.0 in 2025.
  • Its Restructuring Costs was $145000.0 in Q3 2025, compared to $139000.0 in Q2 2025 and $112000.0 in Q1 2025.